Keyphrases
Prospective Cohort Study
100%
X-linked Hypophosphatemia
100%
Bone Turnover
100%
Conventional Therapy
100%
Adult Patients
100%
Bone Mineral Density
100%
Areal Bone Mineral Density (aBMD)
80%
Spine
40%
1,25(OH)2D3
40%
Procollagen Type 1 N-terminal Propeptide (P1NP)
40%
Fibroblast Growth Factor 23 (FGF23)
40%
Calcium Phosphate
40%
Bone Resorption
20%
Phosphate
20%
Biochemical Measures
20%
Linear Regression Model
20%
Treatment Group
20%
Adulthood
20%
Alfacalcidol
20%
Rickets
20%
Total Hip
20%
Osteomalacia
20%
Calcium Homeostasis
20%
Bone Turnover Markers
20%
Bone Mass
20%
Lumbar Spine
20%
Medical Treatment
20%
Renal Tubular Reabsorption
20%
Medicine and Dentistry
Bone Turnover
100%
X Linked Hypophosphatemic Rickets
100%
Prospective Cohort Study
100%
Combination Therapy
100%
Bone Density
100%
Tricalcium Phosphate
40%
Fibroblast Growth Factor 23
40%
Parathyroid Hormone
40%
Osteolysis
20%
Rickets
20%
Prospective Study
20%
Osteomalacia
20%
Lumbar Spine
20%
Calcium Homeostasis
20%
Diseases
20%
Linear Regression Analysis
20%
Alfacalcidol
20%
Dual-Energy X-Ray Absorptiometry
20%
Kidney Tubule Absorption
20%
Bone Mass
20%
Treatment Group
20%
Biochemistry, Genetics and Molecular Biology
Bone Turnover
100%
Prospective Cohort Study
100%
Bone Density
100%
Parathyroid Hormone
40%
Fibroblast Growth Factor 23
40%
Calcium Phosphate
40%
Tricalcium Phosphate
40%
Bone Mass
20%
Rickets
20%
Kidney Tubule Absorption
20%
Osteolysis
20%
Prospective Study
20%
Alfacalcidol
20%
Calcium Homeostasis
20%
Immunology and Microbiology
Bone Density
100%
Bone Turnover
100%
Hip
60%
Vertebral Column
40%
Fibroblast Growth Factor 23
40%
Calcium Homeostasis
20%
Osteolysis
20%
Lumbar Spine
20%
Bone Mass
20%